Although reports have shown evidence for penile length (PL) shortening after radical prostatectomy (RP), the association between neoadjuvant androgen deprivation therapy (NADT) and PL after RP has yet to be determined. This study evaluates chronological changes in PL after NADT and RP. Stretched PLs (SPLs) of 143 patients, 41 of whom had undergone NADT, were measured before, 10 days after, and 1, 3, 6, 9, 12, 18, and 24 months after RP. Chronological erectile function and testosterone levels were then evaluated. SPL was shortest 10 days after RP in both the NADT (À) and NADT (+) groups and gradually recovered in length thereafter. SPL in the NADT (À) group was significantly longer than that in the NADT (+) group before RP. However, no significant differences in SPLs were found between both groups 6 months after RP. Although all subjects in the NADT (+) group had testosterone levels of <50 ng/dL before RP, such levels increased after RP. Before RP, the NADT (À) group was found to have significantly better erectile function than the NADT (+) group. However, differences in erectile function between the NADT (À) and NADT (+) groups after RP were not significant. This report is the first to show that among patients with prostate cancer, those who underwent NADT had greater PL recovery after RP than those who did not. Data regarding PL recovery after NADT and RP obtained in this study could be useful for patients with prostate cancer who plan to undergo such procedures.
INTRODUCTION
Radical prostatectomy (RP) is a standard treatment performed in patients having localized prostate cancer with major complications including urinary incontinence and erectile dysfunction (Ficarra et al., 2012a,b) . Furthermore, one report has shown penile shortening (PS) as another complication of RP (Carlsson et al., 2012) . The vertical repositioning of the membranous urethra, which occurs during urethrovesical anastomosis, has been determined as the mechanism for changes in penile length (PL) after RP (Kadono et al., 2017) . Moreover, long-term histological changes in the penis caused by vascular and nerve injury during RP may possibly affect PL (Mulhall, 2005) . PL and growth rate in infants and adolescents have been reported to significantly correlate with serum testosterone levels (Zacharin & Warne, 1997; Boas et al., 2006) . A few reports have shown a relationship between testosterone levels and penis size in patients with prostate cancer. Long-and short-term androgen deprivation therapy (ADT), as well as radiation therapy, has been reported to shorten PL (Haliloglu et al., 2007) . Currently, neoadjuvant ADT (NADT) before RP is not considered a standard treatment because of its lack of contribution toward improving biochemical recurrent-free survival and overall survival (Schulman et al., 2000; Aus et al., 2002) . However, trials involving new antiandrogen agents or the combination of docetaxel and ADT for high-risk prostate cancer are underway. Self-assessed PS was reportedly associated with low-to-moderate self-esteem. Moreover, patients with prostate cancer who plan to undergo NADT may find information regarding PL after ADT to be beneficial. However, to the best of our knowledge, no studies have investigated changes in PL after NADT. Accordingly, this study evaluates the chronological changes in PL after NADT and RP.
MATERIALS AND METHODS

Patients
Patients with clinically localized prostate cancer undergoing robot-assisted RP (RARP) at the Kanazawa University Hospital (Japan) between January 2011 and December 2014 were included in this study, which was approved by the institutional ethics committee. All patients provided written informed consent before RP, and all data were collected prospectively. At the time of consultation at our hospital, most of the patients had already started NADT; thus, the doctors in charge, who had introduced the patients to our hospital, had previously decided whether to perform NADT or not before the consultation. Those who underwent NADT before RP were identified as NADT (+), whereas those who did not undergo NADT were identified as NADT (À). Patients who underwent NADT for over 3 months were included in the NADT (+) group, while no NADT was performed in the NADT (À) group. Given that the doctor in charge was responsible for determining the duration of NADT, each patient had varying treatment durations. Those who received postoperative ADT and/or radiation therapy or had a history of previous penile disease or surgery were excluded. Prostate-specific antigen levels were measured before prostate biopsy, while the Gleason score was determined during biopsy. PSA and testosterone levels were evaluated in the NADT (+) group. The removed prostate weight was measured just after surgery, and the testosterone levels were evaluated 1-3 years after RP.
RARP
RARP was performed via the transperitoneal approach. Nervesparing procedures, such as inter-or intrafascial dissection, were performed depending on the status of the cancer (Steineck et al., 2015) . The dorsal venous complex was athermally divided without ligation and sutured for hemostasis after division. Doublelayered posterior reconstruction was performed before urethrovesical anastomosis. Urethrovesical anastomosis was performed using a running suture with a double-armed 3-0 monocryl. Urethral catheters were removed 6-8 days postoperatively using cystographic evaluation.
Stretched PL (SPL) measurement SPL was measured from the pubopenile skin junction to the end of the glans with maximum extension by one of the authors (Y.K.), who was blinded to previous measurements. All measurements were taken using a paper ruler and rounded to the nearest 0.5 cm using the standard method (Munding et al., 2001) . SPL was measured with the patient lying in the supine position and the penis placed at a 90°angle to the body before surgery, approximately 3 days after catheter removal, and 1, 3, 6, 9, 12, 18, and 24 months after RP.
MRI and subcutaneous fat thickness
Using a 1.5-T MRI system (Signa HDx; GE Medical Systems, Milwaukee, WI, USA), MRI was performed preoperatively, approximately 3 days after catheter removal, and approximately 12 months after RP. Subcutaneous fat thickness in each patient was also measured at the lower abdomen using the midsagittal MRI plane. Moreover, the thickness measurement at each time point was the average of five different points at 2-cm intervals within the lower abdomen.
Erectile function assessment
Using the erectile function domain of the International Index of Erectile Function (IIEF-EFD) (Rosen et al., 1997) and the Erection Hardness Score (EHS) (Mulhall et al., 2007) , erectile function was assessed preoperatively and 1, 12, and 24 months after RP.
Statistical analysis
Categorical variables were used to calculate the incidence and percentage of each factor, while continuous variables were presented as means AE standard deviations. SPLs between NADT (+) and NADT (À) cases were compared using Student's t-test. Preand postoperative SPLs were compared using paired Student's ttest. Pearson's correlation coefficient and multiple linear regression were used for univariate and multivariate analyses, respectively. All data analyses were performed using SPSS for WINDOWS (SPSS Inc., Chicago, IL, USA). p < 0.05 was considered statistically significant.
RESULTS
Of the 143 patients enrolled in this study who underwent RARP at the Kanazawa University Hospital, 41 underwent NADT. The demographics of the study population are shown in Table 1 . NADT was performed for an average of 7.1 months (ranging from 3 to 27 months) in the NADT (+) group. The average preoperative testosterone level evaluated in 14 patients was 9.4 ng/dL (ranging from 3 to 25 ng/dL). Preoperative PSA levels decreased by an average of 98.5% (ranging from 83.7% to 100%) compared with those before prostate biopsy in patients with NADT. Preoperative sexual function was poorer and excised prostate specimens smaller in the NADT (+) group than in the NADT (À) group. Catheters were removed a median of 7 days after surgery, while SPL was measured immediately after catheter removal and a median of 10 days after RP. Chronological changes in SPL are shown in Fig. 1 . SPL was shortest 10 days after RP in both the NADT (À) and NADT (+) groups and gradually recovered in length thereafter. SPL 12 months after RP did not significantly differ from that obtained preoperatively. In addition, SPL over 12 months after RP was significantly longer than that before RP (Fig. 1A) . A comparison between the NADT (À) and NADT (+) groups revealed a significantly longer SPL in the NADT (À) group than in the NADT (+) group before RP. However, no significant difference in SPL was observed between both groups 6 months after RP (Fig. 1A) . Moreover, the MRI findings showed no significant difference between preoperative and postoperative subcutaneous fat thicknesses in both the NADT (À) and NADT (+) groups. Another comparison between both groups found that sexual function was significantly better in the NADT (À) than in NADT (+) group before RP (Fig. 1B) . However, no significant difference in sexual function was found between both groups after RP ( Fig. 2A,B) . Sexual function in the NADT (+) group before RP was found to be poor. Moreover, differences in sexual function before and after RP in the NADT (+) group were not significant Figure 1 (A) Mean change in penile length among those receiving and not receiving neoadjuvant androgen deprivation therapy-NADT (+) and NADT (À), respectively. SPL, stretched penile length; SD, standard deviation. * ** ***p < 0.05 vs. baseline; * significantly shorter than baseline in the NADT (À) group; ** significantly shorter than baseline in the NADT (+) group; *** significantly longer than baseline in the NADT (+) group; (B) Mean change in subcutaneous fat thickness at the lower abdomen in the NADT (+) and NADT (À) groups. 
NADT (-) NADT (-) NADT (+) NADT (+)
Figure 2 Chronological changes in sexual function among patients receiving and not receiving neoadjuvant androgen deprivation therapy-NADT (+) and NADT (À), respectively. (A) The erectile function domain of the International Index of Erectile Function (IIEF-EFD). (B) The Erection Hardness Score (EHS).
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HORMONE THERAPY AFFECTS PENILE LENGTH until after 12 months when evaluated using IIEF-EFD or after 24 months when evaluated using EHS ( Fig. 2A,B) . Univariate analysis found no predictive factors for SPL improvement in the NADT (+) group 24 months after RP, whereas the p-value of EHS at 2 years after RP was ≤0.1 (Table 2) . Regarding correlation between factors, a correlation coefficient of 0.642 (p < 0.001) was found between the decline rate of PSA by NADT and the duration of NADT, À0.438 (p = 0.004) between age and IIEF-EFD score 24 months after RP, À0.530 (p < 0.001) between age and EHS 24 months after RP, and 0.634 (p < 0.001) between the IIEF-EFD score and EHS 24 months after RP. Accordingly, a multivariate analysis was performed to determine the predictive factors for SPL improvement using BMI, the decline rate in PSA by NADT, EHS 24 months after RP, and postoperative testosterone levels. No predictive factors of SPL recovery 24 months after RP in patients who had undergone NADT were found (Table 2 ).
DISCUSSION
The current study is the first to focus on the effects of NADT on chronological changes in PL after RP. Considering that SPL measurements have been reported to strongly correlate with those for erect PL (Wessells et al., 1996) , SPL measurements of PL have been adopted in many studies (Munding et al., 2001; Savoie et al., 2003; Gontero et al., 2007; Haliloglu et al., 2007; Engel et al., 2011; Park et al., 2011; Vasconcelos et al., 2012; Berookhim et al., 2014; Kadono et al., 2017) . To ensure measurement quality, only one author (Y.K.) who was blinded to previous results performed SPL measurements, and only data from patients who completed the entire 2-year study were included for analysis.
In the current study, SPL was shortest immediately after RP and then gradually recovered to pre-RP levels 12 months after RP both in the NADT (À) and NADT (+) groups. Chronological change patterns for SPL were almost the same in both groups. However, SPL before RP was significantly longer in the NADT (À) group than in the NADT (+) group, while both groups had no significant difference in SPL 6 months after RP and had almost the same SPL 24 months after RP (Fig. 1) . Although testosterone levels in all NADT (+) cases were at castration level (testosterone <50 ng/dL) before RP, such levels increased after RP (after ADT cessation). Two reports have shown the effects of ADT on PL in patients with prostate cancer (Haliloglu et al., 2007; Park et al., 2011) . Haliloglu et al., (2007) observed chronological shortening of SPL after 9 months of ADT and consecutive radiotherapy at 70 Gy by performing evaluations every 3 months until 18 months after treatment initiation (9 months after treatment completion). Using results from 24 months of SPL evaluation, Park et al., (2011) reported that SPLs of patients with localized prostate cancer initially treated with ADT monotherapy continued to decrease until 15 months after treatment initiation and remained unchanged thereafter. Reports have shown that PL and growth rate were correlated with serum testosterone levels in infants and adolescents (Zacharin & Warne, 1997; Boas et al., 2006) . Chen et al., (2015) reported an increase in PLs after the administration of the oral testosterone undecanoate in patients with hypospadias. Although reports have shown a decrease in adult PLs after ADT (Haliloglu et al., 2007; Park et al., 2011) , to the best of our knowledge, this is the first report to show correlation between PL elongation and improvement in testosterone levels even in adults. Previous reports evaluating intermittent ADT have shown that while weight gain was observed during ADT, weight loss was observed during its cessation (Spry et al., 2006) . Therefore, subcutaneous fat thickness, which may affect SPL, was evaluated chronologically. Accordingly, no significant changes in fat thickness had been observed in both the NADT (À) and NADT (+) groups (Fig. 1B) .
Previous reports have shown that slight vertical repositioning of the membranous urethra after RP causes chronological changes in SPL, which were evaluated using chronological MRI findings within 24 months after RP (Kadono et al., 2017) . Considering that injuries to penile nerves and vessels during RP are unavoidable, such injuries could possibly affect PL later on. Results from previous studies on rats have suggested that RP affects PL through cavernous nerve injury-or hypoxia-induced structural alterations in the penis and/or sympathetic hyperinnervation (Mulhall, 2005) . Haliloglu et al., (2007) reported continuous SPL shortening after completing ADT and radiotherapy, which was believed to have been caused by injuries to nerves and vessels due to inflammation from radiotherapy.
The NADT (+) group had poorer erectile function than the NADT (À) group before RP. Moreover, erectile function in both groups worsened just after RP but recovered similarly over time ( Fig. 2A,B) . Administration of PDE5-Is was shown to effectively prevent PL shortening (Berookhim et al., 2014; Montorsi et al., 2014) , while preserved postoperative PL was shown to correlate well with the maintenance of erectile function after nerve-sparing RP (Briganti et al., 2007; Engel et al., 2011) . Although the present study also evaluated predictive factors for SPL elongation 24 months after RP in the NADT (+) group, no significant predictive factors have been found (Table 2) . Despite varying widely, erectile function among our study population was generally poor. Consequently, a small group, such as that in the present study, may probably be insufficient for identifying predictive factors. Although a previous report showed that patients who underwent intermittent ADT were able to recover erectile function after ADT cessation (Niraula et al., 2013) , changes in PL were not reported. One study utilizing a castrated animal model showed greater fibrosis and enhanced apoptosis of the penis tissues (Wang et al., 2015) , while another reported internal pudendal artery dysfunction (Alves-Lopes et al., 2017) . The present study found mean testosterone levels as low as 5 ng/dL just before RP in four patients who had undergone NADT for over 1 year. After RP, however, the mean testosterone levels improved to 308 ng/dL, while SPL was longer than before RP. The present study revealed that PL shortening in patients who had undergone both short-and long-term ADT (over 1 year) was reversible. However, considering that the maximum duration for NADT in this study was 27 months, the reversibility of PL after 27 months remains unclear.
Clinical trials for high-risk prostate cancer using new antiandrogen agents or NADT with docetaxel are underway. Given the possibility for NADT to become one of the treatment strategies for high-risk prostate cancer, the information regarding PL recovery provided herein may be of substantial help.
Some limitations in the current study need to be highlighted. SPL data prior to NADT initiation were not available given that most of the patients had already started NADT upon consultation. Moreover, the duration of NADT was not standardized in each case, while the study population was rather small. The present study was also unable to identify predictive factors for PL elongation after ADT cessation. Therefore, additional investigations will be needed to obtain further information regarding the current field of study.
CONCLUSIONS
This study is the first to show that among patients with prostate cancer, those who had undergone NADT had greater PL recovery after RP than those who did not. PLs in the NADT (+) group were shorter than those in the NADT (À) group just before RP. Therefore, recovery of testosterone levels as a result of ADT cessation is correlated with PL recovery after RP and NADT. Information regarding PL recovery after NADT and RP obtained herein may be considered useful for patients with prostate cancer who plan to undergo such procedures.
